Skip to main content
Eramet logo

Eramet — Investor Relations & Filings

Ticker · ERA ISIN · FR0000131757 LEI · 549300LUH78PG2MP6N64 PA Mining and quarrying
Open in API
Filings indexed 950 across all filing types
Latest filing 2022-02-15 Regulatory Filings
Country FR France
Listing PA ERA

About Eramet

https://www.eramet.com/en

Eramet is a mining and metallurgical group that transforms the Earth's mineral resources. The company's core activities involve the extraction and processing of metals essential for economic development and the energy transition. Its primary products include manganese, nickel, mineral sands (zircon and titanium-containing raw materials), and lithium. Eramet is a leading producer of high-grade manganese ore and alloys, as well as ferronickel. The company is also developing projects in metals critical for electric vehicle batteries, such as lithium and recycled battery materials. Eramet positions itself as a responsible corporate citizen, committed to sustainable practices and the positive transformation of mineral resources.

Recent filings

Filing Released Lang Actions
Eramet : la SLN franchit une étape majeure de son plan
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUÉ DE PRESSE" (Press Release) and announces a significant operational update regarding Eramet's subsidiary, SLN, concerning nickel ore export authorizations granted by the Government of New Caledonia. It details operational milestones, future production targets, and includes quotes from the CEO. Crucially, it also contains a 'Calendrier' section listing future dates for the 'Publication des résultats annuels 2021' (Publication of 2021 annual results) and 'Publication du chiffre d'affaires du Groupe au 1er trimestre 2022' (Publication of Q1 2022 Group revenue). Since this document is an announcement of a major operational/regulatory event, rather than a full financial report (like 10-K or IR) or a transcript, it fits best under the general category for regulatory announcements or significant corporate news that isn't explicitly covered by other codes. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general press release detailing a material operational development, although 'Report Publication Announcement' (RPA) is sometimes used for announcements, this document is substantive news itself, not just an announcement *about* a report. However, since it is a press release announcing a major operational/regulatory decision (export authorization), and not a standard financial report, RNS serves as the best fit among the provided codes for a general, material corporate announcement.
2022-02-15 French
Eramet: SLN takes a major step forward in its plan
Regulatory Filings Classification · 1% confidence The document is titled 'PRESS RELEASE' and announces a specific operational and regulatory development concerning Eramet's subsidiary, SLN, regarding nickel ore export authorizations in New Caledonia. It is a short announcement providing key updates and context, rather than a full financial report (like 10-K or IR) or a transcript. It does not fit the definitions for AGM-R, AR, MANG, CT, CAP, DVA, DLST, DIRS, ER, SR, FS, CGR, IRAT, IP, LTR, TAR, MRQ, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS. While it mentions future 'Publication of 2021 Group annual results' and 'Publication of 2022 Group first-quarter turnover' in the calendar section, the main body is a news announcement about operational permits and strategic steps. This type of material, which is a general corporate announcement outside of specific financial reporting or shareholder actions, best fits the 'Regulatory Filings' (RNS) category as a general regulatory/corporate update, or potentially an Earnings Release (ER) if it were focused on results, but it is clearly an operational update. Given the nature of the announcement (a major operational/regulatory milestone), RNS is the most appropriate general regulatory filing fallback.
2022-02-15 English
Eramet : Finalisation de la cession de l’usine hydro-métallurgique de Sandouville à Sibanye-Stillwater
M&A Activity Classification · 1% confidence The document is titled 'COMMUNIQUE DE PRESSE' (Press Release) and announces the finalization of a major corporate transaction: the sale of a subsidiary (Eramet Sandouville) to Sibanye-Stillwater. This is a significant corporate event announcement. It is not a full annual report (10-K), an interim report (IR), an earnings release (ER), or a management discussion (MDA). It is a specific corporate action announcement. Since there is no specific category for 'Divestiture/Sale Announcement', and it is a material corporate event announcement, it fits best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for significant, non-standard announcements, or potentially 'Capital/Financing Update' (CAP) as it involves a significant cash transaction, but RNS is safer for general material news releases not covered elsewhere. Given the nature of the announcement (completion of a major asset sale), RNS is the most appropriate general regulatory filing category.
2022-02-07 French
Eramet : Informations relatives au nombre total des droits de vote au 31.12.2021
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled with French regulatory references concerning the total number of voting rights and shares ('Informations relatives au nombre total de droits de vote et d'actions'). It provides a snapshot as of December 31, 2021, detailing the total number of shares and the theoretical versus exercisable voting rights. This specific type of mandatory disclosure regarding the capital structure and voting power aligns best with a general regulatory filing or a specific disclosure related to capital/share structure, but given the focus purely on voting rights calculation, it is a specific regulatory disclosure. It is not an AGM presentation, an Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). Since it details the composition of voting rights, it is a specific regulatory disclosure. While it touches upon capital structure, the primary focus is on voting rights calculation, which is often a required periodic filing. Given the options, it is a specific regulatory disclosure. It is not a standard 'Declaration of Voting Results' (DVA) which reports the outcome of a vote, but rather the underlying structure of voting rights. It is closest to a general regulatory filing (RNS) or a specific capital/share structure update. Since it is a mandatory disclosure about the total number of shares and voting rights, it fits best under a general regulatory filing category if a more specific one isn't available. However, since it details the total number of shares and voting rights, it is a fundamental piece of information often disclosed periodically. Given the options, and the lack of a specific 'Voting Rights Disclosure' code, RNS (Regulatory Filings) is the most appropriate fallback for mandatory, non-standard report disclosures.
2022-01-13 French
Bilan quotidien du contrat de liquidité d’Eramet pour la période du 01/07/2021 au 31/12/2021
Transaction in Own Shares Classification · 1% confidence The document title is "Bilan quotidien du contrat de liquidité d'Eramet pour la période du 01/07/2021 au 31/12/2021" (Daily balance sheet of the Eramet liquidity contract for the period from 01/07/2021 to 31/12/2021). It explicitly mentions compliance with AMF Decision n° 2018-01, which relates to liquidity contracts (market making/stabilization activities). This type of regular, detailed reporting on share transactions (buy/sell quantities and capital) related to a liquidity contract is a specific regulatory disclosure. It is not a general earnings release (ER), an interim report (IR), or an annual report (10-K). It is a specific regulatory filing related to market activity/insider transactions, but it is not a Director's Dealing (DIRS) which focuses on executive trades. Given the options, this specialized, periodic report detailing transactions under a liquidity agreement is best classified as a specific regulatory disclosure. Since there isn't a perfect fit for 'Liquidity Contract Daily Balance', we must evaluate the closest categories. It details transactions, which could be related to share activity (POS or DIRS), but the context is regulatory compliance for market stabilization. In many regulatory frameworks, these daily/periodic transaction reports are often grouped under general regulatory filings or specific transaction reports. Since it details the company's own transactions (or transactions managed on its behalf under the contract), 'Transaction in Own Shares' (POS) is a possibility, but 'POS' usually refers to formal share repurchase programs. Given the context of compliance with an AMF decision regarding a 'contrat de liquidité', this is a mandatory regulatory disclosure. If we must choose from the provided list, and recognizing that this is a highly specific, periodic regulatory report that doesn't fit the main financial reports (10-K, IR) or standard announcements (ER, DIV), the most appropriate general regulatory category is 'Regulatory Filings' (RNS), or potentially 'Transaction in Own Shares' (POS) if the liquidity contract is treated as a form of share management. However, 'RNS' is the designated fallback for miscellaneous regulatory filings. Given the highly specific nature of the content (daily liquidity contract balance), and the lack of a dedicated code, RNS is the safest classification for a non-standard regulatory report, although it strongly resembles a specialized transaction report. Let's re-examine the definitions. It is a report detailing transactions, which is the core of POS, but POS is defined as 'Report of the company buying back or selling its own shares'. A liquidity contract involves buying/selling shares to maintain liquidity, which falls under this umbrella. I will classify it as POS due to the transactional nature, as it is more specific than RNS.
2022-01-11 English
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE
Regulatory Filings Classification · 1% confidence The document is titled "BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE" (Semi-annual balance sheet of the liquidity contract) and reports on the activity of a liquidity contract managed by Exane BNP Paribas for ERAMET as of December 31, 2021, covering the second half of 2021. This document details the number of shares and cash held under the liquidity agreement and the transactions executed during the period. This type of regular reporting on market-making or liquidity provision activities, especially when referencing specific regulatory decisions (like AMF decisions), often falls under general regulatory announcements or specific financial reporting not covered by the main forms (10-K, IR, ER). Since it is a specific, periodic report on a financial arrangement (liquidity contract balance), and not a general earnings release (ER) or interim report (IR), it best fits the 'Regulatory Filings' (RNS) category as a specific regulatory disclosure, or potentially a specialized financial disclosure. Given the options, RNS is the most appropriate general regulatory disclosure category for this specific, non-standard report type. The document is short and provides the full details, so it is not an RPA.
2022-01-07 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.